Chemical activators of ZNF99 can engage with the protein through various biochemical pathways to enhance its function. Zinc, as a direct activator, can bind to the zinc-finger motifs of ZNF99, crucial for its structural integrity and function, including DNA binding and interaction with other proteins. Similarly, Forskolin can increase intracellular cyclic AMP (cAMP) levels, leading to the activation of protein kinase A (PKA). PKA can then phosphorylate ZNF99, a post-translational modification that is often associated with protein activation. Ionomycin, by increasing intracellular calcium levels, can activate calcium/calmodulin-dependent protein kinases, which may target ZNF99 for phosphorylation and subsequent activation. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), another kinase that can phosphorylate ZNF99, while Dibutyryl-cAMP, another cAMP analog, similarly engages PKA to phosphorylate and activate ZNF99.
Anisomycin, by acting as an activator of the MAPK pathway, triggers phosphorylation cascades that can encompass ZNF99, leading to its activation. Calyculin A and Okadaic acid both inhibit protein phosphatases, such as PP1 and PP2A, which results in the accumulation of phosphorylated proteins in the cell, potentially including ZNF99, thereby maintaining it in an active state. Thapsigargin disrupts calcium storage and can activate calcium-dependent kinases capable of phosphorylating ZNF99. LY294002, a PI3K inhibitor, may lead to compensatory cellular responses that activate ZNF99. Bisindolylmaleimide I, a PKC inhibitor, paradoxically can lead to the activation of ZNF99 by inducing compensatory pathways within the cell. Lastly, A23187 serves as a calcium ionophore, increasing intracellular calcium and activating calcium/calmodulin-dependent protein kinases, which, in turn, can activate ZNF99. All these chemicals provide a spectrum of activation mechanisms, from direct binding to the initiation of phosphorylation cascades, ensuring the functional activation of ZNF99.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can activate ZNF99 by binding to its zinc-finger domains, which are critical for DNA binding and protein-protein interactions, thus enhancing its function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases that may phosphorylate and activate ZNF99. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates Protein kinase C, which can phosphorylate and thereby activate ZNF99. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cell-permeable cAMP analog, activates PKA, which could lead to the phosphorylation and activation of ZNF99. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin acts as a MAPK activator, leading to phosphorylation cascades that can include the activation of ZNF99 through MAPK-regulated processes. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation levels in cells, which can result in the activation of ZNF99. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid, a potent inhibitor of protein phosphatases 1 and 2A, can lead to hyperphosphorylation of cellular proteins, potentially including ZNF99, activating it. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium storage and can lead to the activation of calcium-dependent kinases that may phosphorylate and activate ZNF99. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, leading to altered AKT signaling; compensatory mechanisms in response to PI3K inhibition can lead to the activation of ZNF99. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I specifically inhibits PKC, which can result in the upregulation of compensatory pathways that activate ZNF99. | ||||||